| Ausstehende Aktien | 543,712,972 shares |
| Insider-Aktien | 92.480.485 shares |
| Insider-Besitz | 17,01 % |
| Insider gesamt | 53 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
1755 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Sorrento Therapeutics, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
II-SO Ltd ABG
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Innovation-SO Ltd ABG
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Management Ltd ABG
10% Owner -
|
1.013.020 | 1.013.020 | |
|
SRNE Ltd ABG
10% Owner -
|
1.013.020 | 1.013.020 | |
| Ernst-guenter Afting Director - [D] | 557.930 | 557.930 | |
|
Ally Bridge Group Capital Partners II, L.P.
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Ally Bridge Group Innovation Capital Partners III, L.P.
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Ally Bridge LB Healthcare Master Fund Ltd
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Bridge LB Management Ltd Ally
10% Owner -
|
1.013.020 | 1.013.020 | |
| Najjam Asghar Chief Financial Officer - [O] | 56.974 | 56.974 | |
|
Pacific MedTech (BVI) Ltd Asia
10% Owner -
|
8.617.513 | 8.617.513 | |
| Elizabeth Czerepak | 350.000 | ||
|
Cambridge Equities, LP
10% Owner -
|
0 | 0 | |
|
Soon-Shiong Family Foundation Chan
10% Owner -
|
0 | 0 | |
| David H Deming | 35.000 | ||
| Mark Durand | 145.000 | ||
| Douglas O Ebersole | 94.000 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Dean Ferrigno Chief Accounting Officer - [O] | 245 | 245 | |
| Dorman Followwill Director - [D] | 2.130 | 2.130 | |
| Cam Gallagher Director - [D] | 0 | 0 | |
|
Nana Gu
10% Owner -
|
8.617.513 | 8.617.513 | |
| Glenn L Halpryn | 140.000 | ||
| Jane Ph D Hsiao Director - [D] | 2.231.719 | 2.231.719 | |
| Kevin Herde Executive VP and CFO - [O] | 7.000 | 7.000 | |
| Kim Janda Director - [D] | 0 | 0 | |
| Henry Ji See Remarks, Director - [D] [O] | 8.597.498 | 8.597.498 | |
| Edgar Lee | 100.000 | ||
| David Lemus | 250.000 | ||
|
Bin Li
10% Owner -
|
1.013.020 | 1.013.020 | |
| Curtis Lockshin | 15.000 | ||
|
MP 13 Ventures, LLC
10% Owner -
|
0 | 0 | |
| William S Marth | 182.000 | ||
| Zhenwei Miao SVP, Head of ADC Development - [O] | 559.390 | 559.390 | |
| George K Ng See Remarks - [O] | 101.453 | 101.453 | |
|
Opko Health, Inc.
10% Owner -
|
2.153.045 | 2.153.045 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Tammy Reilly | 100.000 | ||
|
Donald R Scifres
10% Owner -
|
38.844.714 | 38.844.714 | |
| Jaisim Shah Director - [D] | 112.633 | 112.633 | |
| Patrick Soon-shiong - | 0 | 0 | |
| Michael Scott Salka | 38.000 | ||
| Jiong Shao | 120.000 | ||
| Lewis Shuster Director - [D] | 669.516 | 669.516 | |
| Robin L Smith Director - [D] | 235.000 | 235.000 | |
| Jeffrey Su Executive VP and COO - [O] | 13.000 | 13.000 | |
| Diane D S Tang-Liu | 15.000 | ||
| Vuong Trieu Chief Scientific Officer, Director - [D] [O] | 3.006.641 | 3.006.641 | |
| George Uy See Remarks - [O] | 201.735 | 201.735 | |
| Richard G Vincent | 270.000 | ||
| David Ritchie Webb Director - [D] | 0 | 0 | |
| Yue Alexander Wu Director - [D] | 5.000 | 5.000 | |
|
Fan Yu
10% Owner -
|
1.013.020 | 1.013.020 | |
|
Steve Zaniboni
Director, 10% Owner -
[D]
|
25.484.329 | 25.484.329 | |
| Jerome B Zeldis See Remarks - [O] | 10.000 | 10.000 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in SRNE / Sorrento Therapeutics, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in SRNE / Sorrento Therapeutics, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-17 | 4 | Ji Henry By BioVintage, Inc. | SRNEQ | Common Stock | I | 0,8027 | 19.500 | 16 | 20.000 | ||||
| 2023-02-06 | 2021-03-15 | 5 | Janda Kim | SRNE | Common Stock | D | 10,4243 | -3.000 | -31 | 0 | ||||
| 2022-12-23 | 2022-12-21 | 4 | Ji Henry By BioVintage, Inc. | SRNE | Common Stock | I | 5,5000 | 300 | 2 | 500 | ||||
| 2022-12-23 | 2022-12-02 | 4 | Ji Henry By BioVintage, Inc. | SRNE | Common Stock | I | 5,5000 | 200 | 1 | 200 | ||||
| 2022-12-16 | 2022-12-15 | 4 | Ji Henry | SRNE | Common Stock | D | 1.500.000 | 6.265.805 | ||||||
| 2022-09-07 | 2022-09-07 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0177 | 88.888 | 179 | 4.765.805 | ||||
| 2022-09-06 | 2022-09-06 | 4 | Ji Henry | SRNE | Common Stock | D | 1,9599 | 55.555 | 109 | 4.676.917 | ||||
| 2022-09-02 | 2022-09-02 | 4 | Ji Henry | SRNE | Common Stock | D | 2.500.000 | 4.621.362 | ||||||
| 2022-08-26 | 2022-08-26 | 4 | Ji Henry | SRNE | Common Stock | D | 2,1100 | 33.333 | 70 | 2.121.362 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0596 | 22.222 | 46 | 2.088.029 | ||||
| 2022-06-14 | 2022-06-14 | 4 | Ji Henry | SRNE | Common Stock | D | 1,3999 | 10.000 | 14 | 2.065.807 | ||||
| 2022-05-20 | 2022-05-18 | 4 | CZEREPAK ELIZABETH | SRNE | Stock Option (right to buy) | D | 1,51 | 350.000 | 350.000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | Reilly Tammy | SRNE | Stock Option (right to buy) | D | 1,51 | 100.000 | 100.000 | |||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 4,00 | -3.000 | 0 | |||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Common Stock | D | 5,8800 | -3.000 | -18 | 3.000 | ||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Common Stock | D | 4,0000 | 3.000 | 12 | 6.000 | ||||
| 2021-11-18 | 2021-11-18 | 4 | CZEREPAK ELIZABETH | SRNE | Stock Option (right to buy) | D | 6,01 | 100.000 | 100.000 | |||||
| 2021-09-29 | 2021-09-29 | 4 | Ji Henry | SRNE | Non-qualified stock options | D | 4,00 | -10.000 | 0 | |||||
| 2021-09-29 | 2021-09-29 | 4 | Ji Henry | SRNE | Common Stock | D | 4,0000 | 10.000 | 40 | 2.055.807 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Stock Options | D | 3,57 | -7.357 | 27.643 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Stock Options | D | 1,80 | -35.000 | 0 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 8,0204 | -42.357 | -340 | 3.000 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5700 | 7.357 | 26 | 45.357 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 1,8000 | 35.000 | 63 | 38.000 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 3,50 | -8.000 | 0 | |||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Common Stock | D | 8,0356 | -8.000 | -64 | 3.000 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5000 | 8.000 | 28 | 11.000 | ||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Stock Options | D | 4,89 | -100.000 | 0 | |||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Stock Options | D | 3,95 | -75.000 | 0 | |||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Common Stock | D | 4,8900 | 100.000 | 489 | 235.000 | ||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Common Stock | D | 3,9500 | 75.000 | 296 | 135.000 | ||||
| 2021-08-30 | 2021-08-30 | 4 | Ji Henry | SRNE | Stock option (right to buy) | D | 8,86 | 2.500.000 | 2.500.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Smith Robin L | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Wu Yue Alexander | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | SHAH JAISIM | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Janda Kim | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Lemus David | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Followwill Dorman | SRNE | Stock option (right to buy) | D | 8,86 | 250.000 | 250.000 | |||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 3,50 | -1.900 | 0 | |||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Common Stock | D | 6,9742 | -1.900 | -13 | 3.000 | ||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5000 | 1.900 | 7 | 4.900 | ||||
| 2021-03-17 | 2021-03-16 | 4 | Asghar Najjam | SRNE | Stock Option | D | 10,18 | 100.000 | 100.000 | |||||
| 2021-03-17 | 2021-03-16 | 4 | Asghar Najjam | SRNE | Common Stock | D | 56.974 | 56.974 | ||||||
| 2021-01-26 | 2020-12-16 | 4 | Followwill Dorman | SRNE | Common Stock | D | 7,1350 | -1.000 | -7 | 2.130 | ||||
| 2021-01-26 | 2020-11-11 | 4 | Followwill Dorman | SRNE | Common Stock | D | 1.000 | 3.130 | ||||||
| 2020-11-13 | 2020-11-12 | 4 | Asghar Najjam | SRNE | Stock Option | D | 6,10 | 120.000 | 120.000 | |||||
| 2020-10-20 | 2020-10-16 | 4 | Ji Henry | SRNE | Non-Qualified Stock Option (right to buy) | D | 17,30 | 24.935.882 | 24.935.882 | |||||
| 2020-08-14 | 2020-08-07 | 4 | Janda Kim | SRNE | Stock Options | D | 14,42 | 150.000 | 150.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Smith Robin L | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Ji Henry | SRNE | Stock Options | D | 4,89 | 1.500.000 | 1.500.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Janda Kim | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Followwill Dorman | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Lee Edgar | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Lemus David | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 4,89 | 100.000 | 100.000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Shao Jiong | SRNE | Stock Options | D | 4,89 | 120.000 | 120.000 | |||||
| 2020-03-05 | 2020-03-05 | 4 | Smith Robin L | SRNE | Common Stock | D | 2,2724 | 40.000 | 91 | 60.000 | ||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40.000 | ||||||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40.000 | ||||||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40.000 | ||||||||
| 2019-12-18 | 2019-12-16 | 4 | Smith Robin L | SRNE | Stock Options | D | 3,95 | 75.000 | 75.000 | |||||
| 2019-12-11 | 2019-12-09 | 4 | Lee Edgar | SRNE | Common Stock | D | 3,81 | 75.000 | 75.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Shao Jiong | SRNE | Stock Options | D | 3,78 | 200.000 | 200.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 3,78 | 70.000 | 70.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Followwill Dorman | SRNE | Stock Options | D | 3,78 | 70.000 | 70.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Ji Henry | SRNE | Stock Options | D | 3,78 | 1.500.000 | 1.500.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Janda Kim | SRNE | Stock Options | D | 3,78 | 70.000 | 70.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Lemus David | SRNE | Stock Options | D | 3,78 | 70.000 | 70.000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 3,78 | 70.000 | 70.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Followwill Dorman | SRNE | Stock Options | D | 3,57 | 35.000 | 35.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Janda Kim | SRNE | Stock Options | D | 3,57 | 35.000 | 35.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Lemus David | SRNE | Stock Options | D | 3,57 | 35.000 | 35.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 3,57 | 35.000 | 35.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 3,57 | 35.000 | 35.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Shao Jiong | SRNE | Stock Options | D | 3,57 | 100.000 | 100.000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 3,57 | 100.000 | 100.000 | |||||
| 2018-09-14 | 2018-09-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 4,9159 | -78.677 | -387 | 1.013.020 | ||||
| 2018-09-14 | 2018-09-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 5,0059 | -29.137 | -146 | 1.091.697 | ||||
| 2018-09-14 | 2018-09-12 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 5,0597 | -189.754 | -960 | 1.120.834 | ||||
| 2018-07-23 | 2018-07-20 | 4 | Ji Henry | SRNE | Common Stock | D | 1,75 | -6.000 | 0 | |||||
| 2018-07-23 | 2018-07-20 | 4 | Ji Henry | SRNE | Common Stock | D | 1,7500 | 6.000 | 10 | 2.045.807 | ||||
| 2018-05-17 | 2018-05-17 | 4 | Ji Henry | SRNE | Stock Options | D | 7,20 | 750.000 | 750.000 | |||||
| 2018-02-28 | 2018-02-28 | 4 | Ji Henry | SRNE | Common Stock | D | 9,9500 | 64.600 | 643 | 1.906.177 | ||||
| 2018-02-28 | 2018-02-28 | 4 | Ji Henry | SRNE | Common Stock | I | 124.298 | 260.161 | ||||||
| 2018-02-28 | 2018-02-28 | 4 | Ng George K By Ng Cha Family Trust | SRNE | Common Stock | I | 9,9500 | 90.000 | 895 | 101.453 | ||||
| 2018-02-28 | 2018-02-28 | 4 | Ng George K | SRNE | Common Stock | D | 163.469 | 302.146 | ||||||
| 2018-02-28 | 2018-02-28 | 4 | Ferrigno Dean | SRNE | Common Stock | D | 118 | 245 | ||||||
| 2018-02-08 | 2018-02-07 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 7,1865 | -150.000 | -1.078 | 1.328.529 | ||||
| 2018-02-08 | 2018-02-06 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 6,7541 | -512.912 | -3.464 | 1.478.529 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 8,0038 | -16.973 | -136 | 1.408.027 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 8,0038 | -37.483 | -300 | 3.041.759 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 8,0038 | -16.265 | -130 | 1.310.588 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 7,6527 | -57.037 | -436 | 1.425.000 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 7,6527 | -124.333 | -951 | 3.079.242 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 7,6527 | -53.786 | -412 | 1.326.853 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 7,6063 | -17.963 | -137 | 1.482.037 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 7,6063 | -39.667 | -302 | 3.203.575 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 7,6063 | -17.214 | -131 | 1.380.639 | ||||
| 2018-01-25 | 3/A | Ferrigno Dean | SRNE | Common Stock | D | 63 | ||||||||
| 2018-01-25 | 2018-01-24 | 4 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 7,5156 | -577.962 | -4.344 | 8.617.513 | ||||
| 2018-01-25 | 2018-01-23 | 4 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 7,8246 | -106.326 | -832 | 9.195.475 | ||||
| 2018-01-22 | 2018-01-21 | 4 | Ji Henry | SRNE | Common Stock Warrant (right to buy) | D | 8,50 | 261.438 | 261.438 | |||||
| 2018-01-22 | 2018-01-21 | 4 | Ji Henry | SRNE | Common Stock | D | 1.801.801 | 1.841.577 | ||||||
| 2017-11-16 | 2017-11-14 | 4 | Lemus David | SRNE | Stock Options | D | 2,30 | 35.000 | 35.000 | |||||
| 2017-11-16 | 2017-11-14 | 4 | Followwill Dorman | SRNE | Stock Options | D | 2,30 | 35.000 | 35.000 | |||||
| 2017-10-02 | 3 | Followwill Dorman | SRNE | Common Stock | D | 4.260 | ||||||||
| 2017-10-02 | 3 | Followwill Dorman | SRNE | Common Stock | D | 4.260 | ||||||||
| 2017-09-18 | 2017-09-15 | 4/A | SHAH JAISIM | SRNE | Stock Options | D | 1,80 | 35.000 | 35.000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Janda Kim | SRNE | Stock Options | D | 1,80 | 35.000 | 35.000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Deming David H | SRNE | Stock Options | D | 1,80 | 35.000 | 35.000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Wu Yue Alexander | SRNE | Stock Options | D | 1,80 | 35.000 | 35.000 | |||||
| 2017-09-18 | 2017-09-14 | 4 | Ferrigno Dean | SRNE | Stock Options | D | 1,80 | 25.000 | 25.000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 1,75 | 35.000 | 35.000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 1,75 | 35.000 | 35.000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Janda Kim | SRNE | Stock Options | D | 1,75 | 35.000 | 35.000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Deming David H | SRNE | Stock Options | D | 1,75 | 35.000 | 35.000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 1,80 | 150.000 | 150.000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | Ng George K | SRNE | Stock Options | D | 1,80 | 150.000 | 150.000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | Ji Henry | SRNE | Stock Options | D | 1,80 | 750.000 | 750.000 | |||||
| 2017-09-15 | 2017-09-11 | 4 | Ng George K | SRNE | Common Stock | D | 89.339 | 138.677 | ||||||
| 2017-09-15 | 2017-09-11 | 4 | Ferrigno Dean | SRNE | Common Stock | D | 64 | 127 | ||||||
| 2017-09-15 | 2017-09-11 | 4 | Ji Henry | SRNE | Common Stock | I | 67.932 | 135.863 | ||||||
| 2017-06-15 | 2017-06-15 | 4 | Ji Henry By spouse | SRNE | Common Stock | I | 1,8400 | 9.000 | 17 | 29.001 | ||||
| 2017-06-15 | 2017-06-15 | 4 | Ji Henry By spouse | SRNE | Common Stock | I | 1,8000 | 20.001 | 36 | 20.001 | ||||
| 2017-06-15 | 2017-06-15 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 1,7900 | 10.002 | 18 | 112.633 | ||||
| 2017-05-19 | 3 | Ferrigno Dean | SRNE | Common Stock | D | 126 | ||||||||
| 2017-05-19 | 3 | Ferrigno Dean | SRNE | Common Stock | D | 126 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18.603.602 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18.603.602 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18.603.602 | ||||||||
| 2017-04-21 | 2017-04-19 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited See footnote | SRNE | Common Stock | I | 2,0000 | 550.000 | 1.100 | 1.991.441 | ||||
| 2017-04-19 | 2017-04-19 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0000 | 100.000 | 200 | 139.776 | ||||
| 2017-04-17 | 2017-04-13 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 2,0000 | 1.500.000 | 3.000 | 1.500.000 | ||||
| 2017-04-17 | 2017-04-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 2,0000 | 1.000.000 | 2.000 | 1.397.853 | ||||
| 2017-02-22 | 2017-02-22 | 4 | Ji Henry | SRNE | Common Stock | D | 5,6000 | 2.000 | 11 | 39.776 | ||||
| 2017-02-10 | 2017-02-10 | 4/A | Ji Henry | SRNE | Common Stock | D | 5,1500 | 20.000 | 103 | 37.776 | ||||
| 2017-02-03 | 2017-02-03 | 4 | ZELDIS JEROME B | SRNE | Common Stock | D | 5,1500 | 10.000 | 52 | 10.000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 5,1500 | 10.000 | 52 | 102.631 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Ng George K | SRNE | Common Stock | D | 5,1500 | -40.000 | -206 | 49.338 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Ji Henry | SRNE | Common Stock | D | 5,1500 | 20.000 | 103 | 37.776 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Herde Kevin | SRNE | Common Stock | D | 5,1500 | 3.000 | 15 | 7.000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Su Jeffrey | SRNE | Common Stock | D | 5,1500 | 4.000 | 21 | 13.000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Janda Kim | SRNE | Common Stock | D | 5,1500 | 3.000 | 15 | 3.000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Wu Yue Alexander | SRNE | Common Stock | D | 5,1500 | 5.000 | 26 | 5.000 | ||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 3.243.242 | 3.243.242 | ||||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 1.441.441 | 1.441.441 | ||||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 397.853 | 397.853 | ||||||
| 2016-11-15 | 2016-08-12 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 6,52 | 200.000 | 200.000 | |||||
| 2016-11-14 | 2016-11-11 | 4 | Ji Henry | SRNE | Stock Options | D | 6,52 | -200.000 | 300.000 | |||||
| 2016-11-09 | 2016-11-08 | 4 | Ng George K | SRNE | Common Stock | D | 89.338 | 90.226 | ||||||
| 2016-11-09 | 2016-11-08 | 4 | Ji Henry | SRNE | Common Stock | I | 67.931 | 67.931 | ||||||
| 2016-08-16 | 2016-08-12 | 4 | Su Jeffrey | SRNE | Stock Options | D | 6,52 | 100.000 | 260.000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Herde Kevin | SRNE | Stock Options | D | 6,52 | 50.000 | 130.000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Ng George K | SRNE | Stock Options | D | 6,52 | 100.000 | 260.000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Ji Henry | SRNE | Stock Options | D | 6,52 | 500.000 | 977.000 | |||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5.480.389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8.325.778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6.523.977 | ||||||||
| 2016-07-12 | 2016-07-11 | 4 | Deming David H | SRNE | Stock Options | D | 6,44 | 35.000 | 105.000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | Janda Kim | SRNE | Stock Options | D | 6,44 | 35.000 | 132.400 | |||||
| 2016-07-12 | 2016-07-11 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 6,44 | 35.000 | 305.000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 6,44 | 35.000 | 94.000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | Marth William S | SRNE | Stock Options | D | 6,44 | 49.000 | 182.000 | |||||
| 2016-07-11 | 2016-07-08 | 4 | SOON-SHIONG PATRICK Through Cambridge Equities, LP | SRNE | Warrant | I | 5,80 | -500.000 | 1.224.138 | |||||
| 2016-07-11 | 2016-07-07 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | -7.878.098 | 0 | ||||||
| 2016-07-11 | 2015-07-28 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 720.174 | 7.878.098 | ||||||
| 2016-07-11 | 2015-07-28 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | -720.174 | 0 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8190 | -3.400 | -20 | 7.157.924 | ||||
| 2016-06-24 | 2016-06-23 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8540 | -6.901 | -40 | 7.161.324 | ||||
| 2016-06-17 | 2016-06-15 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8720 | -19.836 | -116 | 7.168.225 | ||||
| 2016-06-15 | 2016-06-14 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1140 | -15.972 | -98 | 720.174 | ||||
| 2016-06-15 | 2016-06-13 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1450 | -37.792 | -232 | 736.146 | ||||
| 2016-04-08 | 3 | Herde Kevin | SRNE | Common Stock | D | 8.000 | ||||||||
| 2016-04-08 | 3 | Herde Kevin | SRNE | Common Stock | D | 8.000 | ||||||||
| 2016-03-15 | 2016-03-11 | 4 | Ji Henry | SRNE | Stock Options | D | 5,79 | 100.000 | 477.000 | |||||
| 2016-03-15 | 2016-03-11 | 4 | Su Jeffrey | SRNE | Stock Options | D | 5,79 | 40.000 | 160.000 | |||||
| 2016-03-15 | 2016-03-11 | 4 | Ng George K | SRNE | Stock Options | D | 5,79 | 40.000 | 160.000 | |||||
| 2016-03-08 | 2016-03-07 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1700 | -85.300 | -526 | 773.938 | ||||
| 2016-03-08 | 2016-03-04 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,3400 | -14.700 | -93 | 859.238 | ||||
| 2016-03-01 | 2015-07-24 | 5 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 7.188.061 | 7.188.061 | ||||||
| 2016-03-01 | 2015-07-24 | 5 | SOON-SHIONG PATRICK Through Cambridge Equities, LP | SRNE | Common Stock | I | -7.188.061 | 0 | ||||||
| 2016-03-01 | 3 | Chan Soon-Shiong Family Foundation | SRNE | Common Stock | D | 14.376.122 | ||||||||
| 2016-03-01 | 3 | Chan Soon-Shiong Family Foundation | SRNE | Common Stock | D | 14.376.122 | ||||||||
| 2015-12-10 | 2015-12-09 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 7,9291 | 39.764 | 315 | 873.938 | ||||
| 2015-12-09 | 2015-12-08 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 8,0110 | 14.000 | 112 | 834.174 | ||||
| 2015-12-09 | 2015-12-07 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 7,8909 | 100.000 | 789 | 820.174 | ||||
| 2015-11-02 | 3 | Su Jeffrey | SRNE | Common Stock | D | 18.000 | ||||||||
| 2015-11-02 | 3 | Su Jeffrey | SRNE | Common Stock | D | 18.000 | ||||||||
| 2015-09-21 | 2015-09-18 | 4 | Uy George | SRNE | Common Stock | D | -47.500 | 201.735 | ||||||
| 2015-08-26 | 2015-08-26 | 4 | Ji Henry | SRNE | SRNE 35 March 2016 Call Options | D | 0,5000 | 3 | 0 | 500 | ||||
| 2015-08-26 | 2015-08-26 | 4 | Ji Henry | SRNE | SRNE 35 March 2016 Call Options | D | 0,9500 | 497 | 0 | 497 | ||||
| 2015-08-24 | 2015-08-24 | 4 | Ji Henry | SRNE | Common Stock | D | 12,8430 | 8.888 | 114 | 17.776 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,3400 | 55 | 1 | 888 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,5460 | 333 | 5 | 833 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,4900 | 500 | 7 | 500 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ji Henry | SRNE | Common Stock | D | 13,0760 | 8.888 | 116 | 14.888 | ||||
| 2015-08-05 | 2015-08-03 | 4 | Ng George K Through Peng Ventures, LLC | SRNE | Common Stock | I | 11,5000 | 11.453 | 132 | 14.901 | ||||
| 2015-08-05 | 2015-08-03 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 11,5000 | 27.189 | 313 | 92.631 | ||||
| 2015-06-08 | 2015-06-04 | 4 | Marth William S | SRNE | Stock Options | D | 13,79 | 58.000 | 133.000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | Janda Kim | SRNE | Stock Options | D | 13,79 | 28.000 | 97.400 | |||||
| 2015-06-08 | 2015-06-04 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 13,79 | 34.000 | 59.000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 13,79 | 25.000 | 270.000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | Deming David H | SRNE | Stock Options | D | 13,79 | 36.000 | 61.000 | |||||
| 2015-05-22 | 2015-05-21 | 4 | Miao Zhenwei | SRNE | Common Stock | D | -40.000 | 559.390 | ||||||
| 2015-05-01 | 2015-04-29 | 4 | Durand Mark | SRNE | Stock Options | D | 8,95 | 120.000 | 145.000 | |||||
| 2015-04-06 | 3/A | Ng George K Through Peng Ventures, LLC | SRNE | Common Stock | I | 3.448 | ||||||||
| 2015-02-26 | 2015-02-24 | 4 | Uy George | SRNE | Stock Options | D | 12,78 | 80.000 | 207.000 | |||||
| 2015-02-26 | 2015-02-24 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 12,78 | 80.000 | 245.000 | |||||
| 2015-02-26 | 2015-02-24 | 4 | Ji Henry | SRNE | Stock Options | D | 12,78 | 160.000 | 377.000 | |||||
| 2015-01-05 | 2015-01-02 | 4 | Ji Henry | SRNE | Common Stock | I | 10,1600 | -10.000 | -102 | 2.043.162 | ||||
| 2015-01-05 | 2014-12-31 | 4 | Ji Henry | SRNE | Common Stock | I | 10,0700 | -15.000 | -151 | 2.053.162 | ||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15.096.296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8.628.409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8.628.409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8.628.409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15.096.296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15.096.296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15.096.296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8.628.409 | ||||||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8600 | 2.500 | 12 | 16.999 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8500 | 400 | 2 | 14.499 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8400 | 100 | 0 | 14.099 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8100 | 799 | 4 | 13.999 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8000 | 1.200 | 6 | 13.200 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,7700 | 1.000 | 5 | 12.000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,6000 | 1.000 | 5 | 11.000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5700 | 1.000 | 5 | 10.000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5500 | 1.000 | 5 | 9.000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5300 | 1.000 | 5 | 8.000 | ||||
| 2014-11-06 | 2014-11-06 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5000 | 1.000 | 4 | 7.000 | ||||
| 2014-11-06 | 2014-11-06 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5500 | 2.000 | 9 | 6.000 | ||||
| 2014-10-09 | 2014-10-07 | 4 | VINCENT RICHARD G | SRNE | Stock Options | D | 4,32 | 50.000 | 270.000 | |||||
| 2014-10-09 | 2014-10-07 | 4 | Ji Henry | SRNE | Stock Options | D | 4,32 | 100.000 | 308.000 | |||||
| 2014-10-09 | 2014-10-07 | 4 | Miao Zhenwei | SRNE | Stock Options | D | 4,32 | 50.000 | 86.000 | |||||
| 2014-09-29 | 2014-09-26 | 4 | Ji Henry | SRNE | Common Stock | I | -20.000 | 2.068.162 | ||||||
| 2014-09-22 | 2014-09-18 | 4 | Janda Kim | SRNE | Stock Options | D | 4,78 | 12.500 | 69.400 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Uy George | SRNE | Stock Options | D | 4,78 | 80.000 | 127.000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 4,78 | 12.000 | 25.000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Durand Mark | SRNE | Stock Options | D | 4,78 | 12.000 | 25.000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Marth William S | SRNE | Stock Options | D | 4,78 | 25.000 | 75.000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 4,78 | 25.000 | 165.000 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Ji Henry | SRNE | Common Stock | I | -250.000 | 2.088.162 | ||||||
| 2014-04-15 | 3 | Miao Zhenwei | SRNE | Common Stock | D | 1.198.780 | ||||||||
| 2014-04-15 | 3 | Miao Zhenwei | SRNE | Common Stock | D | 1.198.780 | ||||||||
| 2014-01-24 | 2014-01-23 | 4 | Gallagher Cam | SRNE | Stock Options | D | 9,82 | 10.000 | 35.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Salka Michael Scott | SRNE | Stock Options | D | 9,82 | 10.000 | 38.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Marth William S | SRNE | Stock Options | D | 9,82 | 37.000 | 50.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Janda Kim | SRNE | Stock Options | D | 9,82 | 10.000 | 56.900 | |||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5500 | 300 | 3 | 1.727.162 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5400 | 100 | 1 | 1.726.862 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5296 | 100 | 1 | 1.726.762 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5275 | 500 | 4 | 1.726.662 | ||||
| 2013-12-05 | 2013-12-05 | 4 | Ji Henry | SRNE | Common Stock | D | 8,9500 | 500 | 4 | 1.728.162 | ||||
| 2013-12-05 | 2013-12-05 | 4 | Ji Henry | SRNE | Common Stock | D | 8,8800 | 500 | 4 | 1.727.662 | ||||
| 2013-11-27 | 2013-11-26 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5400 | -8.714 | -74 | 2.153.045 | ||||
| 2013-11-27 | 2013-11-25 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5409 | -12.100 | -103 | 2.161.759 | ||||
| 2013-11-26 | 2013-11-25 | 4 | SHAH JAISIM By Spouse | SRNE | Common Stock | I | 8,6500 | 1.000 | 9 | 65.442 | ||||
| 2013-11-25 | 2013-11-22 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,4990 | -8.471 | -72 | 2.173.859 | ||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Convertible Notes | D | 7,50 | 0 | 0 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Common Stock | D | 7,5000 | 4.842 | 36 | 179.307 | ||||
| 2013-11-22 | 2013-10-29 | 4/A | Uy George | SRNE | Stock Options | D | 8,40 | 47.000 | 47.000 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Convertible Notes | D | 7,25 | 0 | 0 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Common Stock | D | 7,2500 | 4.842 | 35 | 179.307 | ||||
| 2013-11-22 | 2013-10-29 | 4/A | Uy George | SRNE | Stock Options | D | 8,40 | 47.000 | 47.000 | |||||
| 2013-11-22 | 2013-11-21 | 4 | Uy George | SRNE | Common Stock | D | 8,5700 | 1.000 | 9 | 184.338 | ||||
| 2013-11-22 | 2013-11-21 | 4 | Uy George | SRNE | Common Stock | D | 8,2500 | 2.000 | 16 | 183.338 | ||||
| 2013-11-22 | 2013-11-22 | 4 | Ji Henry | SRNE | Common Stock | D | 8,4660 | 1.000 | 8 | 1.726.162 | ||||
| 2013-11-22 | 2013-11-21 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5276 | -4.269 | -36 | 2.182.330 | ||||
| 2013-11-21 | 2013-11-20 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -16.962 | -148 | 2.186.599 | ||||
| 2013-11-21 | 2013-11-19 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -100 | -1 | 2.203.561 | ||||
| 2013-11-20 | 2013-11-19 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 9,0000 | 1.000 | 9 | 64.442 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Uy George | SRNE | Common Stock | D | 8,7200 | 1.000 | 9 | 181.338 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Uy George | SRNE | Common Stock | D | 8,5000 | 1.031 | 9 | 180.338 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | 8,6000 | 1.000 | 9 | 1.725.162 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | 8,5890 | 1.000 | 9 | 1.724.162 | ||||
| 2013-11-18 | 2013-11-15 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -2.710 | -24 | 2.203.661 | ||||
| 2013-11-15 | 2013-11-14 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -1.900 | -17 | 2.206.371 | ||||
| 2013-11-14 | 2013-11-13 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -13.457 | -118 | 2.208.271 | ||||
| 2013-11-12 | 2013-11-08 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | -2.000 | -18 | 2.221.728 | ||||
| 2013-11-08 | 2013-11-07 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 9,0721 | -5.418 | -49 | 2.223.728 | ||||
| 2013-11-08 | 2013-11-06 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 9,0300 | -114.962 | -1.038 | 2.229.146 | ||||
| 2013-10-31 | 2013-10-29 | 4 | Salka Michael Scott | SRNE | Stock Options | D | 8,40 | 9.000 | 28.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Uy George | SRNE | Stock Options | D | 8,40 | 47.000 | 47.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 8,40 | 80.000 | 140.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | VINCENT RICHARD G | SRNE | Stock Options | D | 8,40 | 100.000 | 220.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Gallagher Cam | SRNE | Stock Options | D | 8,40 | 9.000 | 25.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Ji Henry | SRNE | Stock Options | D | 8,40 | 101.000 | 117.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Webb David Ritchie | SRNE | Stock Options | D | 8,40 | 11.000 | 29.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Janda Kim | SRNE | Stock Options | D | 8,40 | 9.000 | 46.900 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Trieu Vuong | SRNE | Stock Options | D | 8,40 | 36.000 | 36.000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | AFTING ERNST-GUENTER | SRNE | Stock Options | D | 8,40 | 9.000 | 26.600 | |||||
| 2013-10-23 | 2013-10-21 | 4 | Uy George | SRNE | Convertible Note | D | 35.000,0000 | 0 | 0 | 0 | ||||
| 2013-09-27 | 2013-09-25 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -2.000 | 1.723.162 | ||||||
| 2013-09-20 | 3 | SHAH JAISIM | SRNE | Common Stock | D | 0 | ||||||||
| 2013-09-19 | 3 | Trieu Vuong | SRNE | Common Stock | D | 3.006.641 | ||||||||
| 2013-09-19 | 3 | Uy George | SRNE | Common Stock | D | 0 | ||||||||
| 2013-09-04 | 2013-09-04 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,0100 | -55 | -0 | 2.344.108 | ||||
| 2013-09-04 | 2013-09-04 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | -9.300 | -72 | 2.344.163 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | -100 | -1 | 2.353.463 | ||||
| 2013-08-28 | 2013-08-28 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | -641 | -5 | 2.353.563 | ||||
| 2013-08-28 | 2013-08-26 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,0000 | -1.615 | -13 | 2.354.204 | ||||
| 2013-08-21 | 2013-08-20 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7788 | -1.560 | -12 | 2.355.819 | ||||
| 2013-08-16 | 2013-08-14 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,9500 | -2.900 | -26 | 2.357.379 | ||||
| 2013-08-15 | 2013-08-07 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,5000 | -331 | -3 | 2.360.279 | ||||
| 2013-07-05 | 2013-07-03 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -25.000 | 43.129.032 | ||||||
| 2012-10-19 | 2012-09-30 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock option | D | 0,16 | -725.000 | 2.275.000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Webb David Ritchie | SRNE | Non-qualified stock option | D | 0,14 | -37.500 | 0 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Webb David Ritchie | SRNE | Non-qualified stock option | D | 0,16 | 450.000 | 450.000 | |||||
| 2012-10-19 | 2012-09-30 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock option | D | 0,16 | -725.000 | 2.275.000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Salka Michael Scott | SRNE | Non-qualified stock option | D | 0,16 | 400.000 | 400.000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Salka Michael Scott | SRNE | Call option | D | 0,16 | -300.000 | 0 | |||||
| 2012-10-19 | 2012-10-17 | 4 | AFTING ERNST-GUENTER | SRNE | Non-qualified stock option | D | 0,16 | 400.000 | 400.000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Gallagher Cam | SRNE | Non-qualified stock option | D | 0,16 | 400.000 | 400.000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 400.000 | 400.000 | |||||
| 2012-09-25 | 2012-09-22 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock options | D | 0,16 | 3.000.000 | 3.000.000 | |||||
| 2012-09-13 | 3 | Gallagher Cam | SRNE | No securities beneficially owned | D | 0 | ||||||||
| 2012-09-13 | 3 | Webb David Ritchie | SRNE | No securities beneficially owned. | D | 0 | ||||||||
| 2012-07-20 | 2012-07-20 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,16 | 15.000 | 15.000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Salka Michael Scott | SRNE | Non-qualified stock options | D | 0,16 | 15.000 | 15.000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 25.000 | 25.000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Tang-Liu Diane D S | SRNE | Non-qualified stock options | D | 0,16 | 15.000 | 15.000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | SCIFRES DONALD R | SRNE | Call Option (Obligation to Sell) | I | 0,16 | -300.000 | 300.000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | Salka Michael Scott | SRNE | Call Option (right to buy) | D | 0,16 | 300.000 | 300.000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | Ji Henry Footnote 1 | SRNE | Common Stock | I | 0,1600 | 6.250.000 | 1.000 | 6.250.000 | ||||
| 2012-04-03 | 2012-03-30 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -150.000 | 43.154.032 | ||||||
| 2012-02-28 | 2012-02-23 | 4 | Tang-Liu Diane D S | SRNE | Non-qualified stock options | D | 0,16 | 60.000 | 60.000 | |||||
| 2012-02-27 | 2012-02-23 | 4 | Salka Michael Scott | SRNE | Non-qualified stock options | D | 0,16 | 60.000 | 60.000 | |||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -150.000 | 43.304.032 | ||||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -150.000 | 43.454.032 | ||||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | -150.000 | 43.604.032 | ||||||
| 2012-02-09 | 2011-12-29 | 5/A | SCIFRES DONALD R | SRNE | Common Stock | I | 0,1600 | 12.500.000 | 2.000 | 38.844.714 | ||||
| 2012-02-09 | 2011-08-28 | 5/A | SCIFRES DONALD R | SRNE | Common Stock | I | -9.813.880 | 26.344.714 | ||||||
| 2012-02-07 | 2012-02-06 | 4 | Ji Henry | SRNE | Non-qualified stock options | D | 0,16 | 250.000 | 250.000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock options | D | 0,16 | 125.000 | 125.000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,16 | 100.000 | 100.000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 75.000 | 75.000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | HSIAO JANE PH D | SRNE | Non-qualified stock options | D | 0,16 | 75.000 | 75.000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | HALPRYN GLENN L | SRNE | Non-qualified stock option | D | 0,16 | 140.000 | 140.000 | |||||
| 2012-01-06 | 2011-12-29 | 5 | SCIFRES DONALD R | SRNE | Common Stock | I | 0,1600 | 12.500.000 | 2.000 | 48.658.594 | ||||
| 2010-02-26 | 2010-02-05 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,07 | 15.000 | 55.000 | |||||
| 2010-02-26 | 2010-02-05 | 4 | HALPRYN GLENN L | SRNE | Non-qualified stock option | D | 0,07 | 10.000 | 50.000 | |||||
| 2010-02-05 | 3 | ZANIBONI STEVE | SRNE | Common Stock | D | 25.484.329 | ||||||||
| 2010-01-27 | 3 | HSIAO JANE PH D By partnership | SRNE | Common Stock | I | 2.231.719 | ||||||||
| 2009-09-23 | 3 | Ji Henry | QBSW | Common Stock | D | 1.785.375 | ||||||||
| 2009-09-23 | 3 | Shuster Lewis | QBSW | Common Stock | D | 669.516 | ||||||||
| 2009-09-23 | 3 | AFTING ERNST-GUENTER | QBSW | Common Stock | D | 557.930 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
